tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
EDIT is currently covered by 16 analysts with an average price target of $5.43. This is a potential upside of $2.99 (122.54%) from yesterday's end of day stock price of $2.44.
Editas Medicine's activity chart (see below) currently has 72 price targets and 96 ratings on display. The stock rating distribution of EDIT is 47.92% BUY, 45.83% HOLD and 6.25% SELL.
Analysts average stock forecasts to be materialized ratio is 45.65% with an average time for these price targets to be met of 135.56 days.
Highest price target for EDIT is $20, Lowest price target is $5, average price target is $5.43.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 05-Nov-2024. First documented stock forecast 29-Feb-2016.
Currently out of the existing stock ratings of EDIT, 23 are a BUY (47.92%), 22 are a HOLD (45.83%), 3 are a SELL (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$2.34 (87.97%)
$7
17 days ago
(05-Nov-2024)
5/9 (55.56%)
$1.93 (62.87%)
235
Buy
$11
$8.34 (313.53%)
$9
17 days ago
(05-Nov-2024)
3/6 (50%)
$7.93 (258.31%)
28
Buy
$7
$4.34 (163.16%)
$9
17 days ago
(05-Nov-2024)
2/7 (28.57%)
$3.93 (128.01%)
50
Hold
$5
$2.34 (87.97%)
$8
17 days ago
(05-Nov-2024)
3/8 (37.5%)
$1.93 (62.87%)
59
Buy
$17
18 days ago
(04-Nov-2024)
5/6 (83.33%)
$5.53 (48.21%)
352
What is EDIT (Editas Medicine) average time for price targets to be met?
Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?
Which analyst has the most public recommendations on EDIT (Editas Medicine)?
Which analyst is the currently most bullish on EDIT (Editas Medicine)?
Which analyst is the currently most reserved on EDIT (Editas Medicine)?
